NCT03276325View on ClinicalTrials.gov

Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

January 7, 2018

Conditions
Lower Abdominal Oncologic Surgery
Interventions
DRUG

Placebo-nalbuphine

Epidural injection of normal saline followed with intrathecal injection of 0.6 mg nalbuphine in conjunction with 4 ml of hyperbaric bupivacaine 0.5%

DRUG

Dexamethasone-nalbuphine

Epidural injection of dexamethasone followed with intrathecal injection of 0.6 mg nalbuphine in conjunction with 4 ml of hyperbaric bupivacaine 0.5%

Trial Locations (1)

050

Mansoura University, Faculty of Medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03276325 - Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery | Biotech Hunter | Biotech Hunter